Ontario – To support the next phase of Taking Life Sciences to the Next Level, Ontario’s life sciences strategy, the province is establishing a Life Sciences Council. This new council will explore ways to support the creation of good-paying jobs, accelerate commercialization and encourage the adoption of Ontario-made innovations to improve health care and grow the economy. Building on previous sector consultations, the council and its five subcommittees will provide insight to help address sector challenges and find opportunities to increase competitiveness.
The council is made up of the following 12 people:
- Dr. Jason Field (Chair) – President and CEO of Life Sciences Ontario
- Dr. Dozie Amuzie – Head of Johnson & Johnson Innovation for JLABS Canada
- Dr. Maura Campbell – CEO of the Ontario Bioscience Innovation Organization
- Nicole DeKort – President and CEO of Medtech Canada
- Pamela Fralick – President of Innovative Medicines Canada
- Elliot Fung – Executive Director of Medical Innovation Xchange
- Jim Keon – President of the Canadian Generic Pharmaceutical Association
- Cameron Love – President and CEO of The Ottawa Hospital
- Dr. Michael May – President and CEO of the Centre for Commercialization of Regenerative Medicine
- Dr. Derek Newton – Assistant Vice-President, Innovation, Partnerships and Entrepreneurship at the University of Toronto
- Dr. David O’Neill – President of FACIT
- Dr. Jane Philpott – Dean of the Faculty of Health Sciences and Director of the School of Medicine at Queen’s University and CEO of the Southeastern Ontario Academic Medical Organization